Health · Pharma & Biotech · 54 mins ago
Wegovy pill users lost an average 6.2% of body weight in three months
Novo Nordisk’s Wegovy pill users lost an average 6.2% of their weight over three months, according to real-world data.
The analysis involved 5,872 adults on the Ro telehealth platform in the United States who had not previously taken a weight-loss drug and stayed on the pill for the full three months.
Participants started treatment between January 5 and February 7, 2026, and lost an average of 6.3 kilograms from a starting average weight of 103 kilograms.
About three in five lost at least 5% of their weight, while roughly one in six lost at least 10%.
The results broadly matched Novo’s clinical trial finding of 5.5% weight loss after 12 weeks, but they apply to people who remained on treatment for the full period.
The data will be presented at the ObesityWeek conference in Washington, as Novo competes with Eli Lilly in the market for oral obesity drugs.
Patients who stayed on Novo Nordisk’s daily Wegovy pill lost an average of 6.2% of their body weight over three months, according to real-world data.
The analysis covered 5,872 adults on the Ro telehealth platform who had never taken a weight-loss drug.
Participants lost an average of 6.3 kilograms from a baseline weight of 103.0 kilograms.
About three-fifths of participants lost at least 5% of their weight, and roughly one in six lost at least 10%.
The data are due to be presented at the ObesityWeek conference in Washington.
- Who
- 5,872 adults taking Novo Nordisk’s Wegovy pill through the Ro telehealth platform.
- What
- Participants who stayed on the pill for three months lost an average of 6.2% of their body weight.
- When
- Participants started taking the pill between January 5 and February 7, 2026, and stayed on it for three months.
- Where
- The analysis covered patients on the Ro telehealth platform; the data are due to be presented in Washington.
- Why
- Not stated.
This story does not have two clearly opposing sides.
Novo Nordisk launched the Wegovy pill.
Study participants started taking the pill.
Participants who stayed on the pill had lost an average of 6.2% of their body weight.
The real-world data are due to be presented in Washington.
- Average weight loss
- 6.2% over three months
- Participants
- 5,872 adults
- Average weight lost
- 6.3 kg (13.9 pounds)
- Baseline average weight
- 103.0 kg (227 pounds)
- At least 5% weight loss
- About three-fifths of participants
- At least 10% weight loss
- Roughly one in six participants